Augmentation of Docetaxel-Induced Cytotoxicity in Human PC-3 Androgen-Independent Prostate Cancer Cells by Combination With Four Natural Apoptosis-Inducing Anticancer Compounds

Docetaxel (DTX) is the treatment of choice for metastatic castration-resistant prostate cancer. However, developing drug resistance is a significant challenge for achieving effective therapy. This study evaluated the anticancer and synergistic effects on DTX of four natural compounds (calebin A, 3(′...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Inass A, Hafiz, Saly, van Ginkel, Sabrina, Pondugula, Satyanarayana R, Abdelhaffez, Azza S, Sayyed, Hayam G, El-Aziz, Ebtihal A Abd, Mansour, Mahmoud M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249917/
https://www.ncbi.nlm.nih.gov/pubmed/37292146
http://dx.doi.org/10.1177/1934578x231175323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249917/
https://www.ncbi.nlm.nih.gov/pubmed/37292146
http://dx.doi.org/10.1177/1934578x231175323

Ejemplares similares